SONY Set to Report Q4 Earnings: Key Takeaways for Investors — Positive
SONY Zacks Investment Research — May 12, 2025Sony's Q4 performance is likely to have benefited from elevated demand across G&NS, Music and Financial Services units amid soft trends in the ET&S business.
Construction Partners' Q2 Earnings Beat Estimates, FY25 View Up — Positive
ROAD Zacks Investment Research — May 12, 2025ROAD's fiscal second-quarter results benefit from strong operational performance throughout the Sunbelt.
GameStop Trading at a Premium: Should You Restrain Buying GME Stock? — Positive
GME Zacks Investment Research — May 12, 2025GameStop Corp. GME, which sparked the meme-stock revolution, continues to defy conventional market logic. While its fundamentals have yet to catch up with its lofty valuation, retail investor enthusiasm remains strong.
HCI Group, Inc. (HCI) Hit a 52 Week High, Can the Run Continue? — Positive
HCI Zacks Investment Research — May 12, 2025HCI Group (HCI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Axis Capital Holdings Limited (AXS) Soars to 52-Week High, Time to Cash Out? — Positive
AXS Zacks Investment Research — May 12, 2025Axis Capital (AXS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Centuri Holdings (CTRI) Reports Q1 Loss, Tops Revenue Estimates — Negative
CTRI Zacks Investment Research — May 12, 2025Centuri Holdings (CTRI) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $137.53 per share a year ago.
CervoMed Inc. (CRVO) Reports Q1 Loss, Tops Revenue Estimates — Negative
CRVO Zacks Investment Research — May 12, 2025CervoMed Inc. (CRVO) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.41 per share a year ago.
Urogen Pharma (URGN) Reports Q1 Loss, Lags Revenue Estimates — Negative
URGN Zacks Investment Research — May 12, 2025Urogen Pharma (URGN) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to loss of $0.97 per share a year ago.
What Analyst Projections for Key Metrics Reveal About Cava (CAVA) Q1 Earnings — Positive
CAVA Zacks Investment Research — May 12, 2025Besides Wall Street's top -and-bottom-line estimates for Cava (CAVA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Take-Two (TTWO) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates — Neutral
TTWO Zacks Investment Research — May 12, 2025Evaluate the expected performance of Take-Two (TTWO) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Fox Corporation (FOX) Surpasses Q3 Earnings and Revenue Estimates — Positive
FOX Zacks Investment Research — May 12, 2025Fox Corporation (FOX) came out with quarterly earnings of $1.10 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.09 per share a year ago.
Unlocking Q2 Potential of Deere (DE): Exploring Wall Street Estimates for Key Metrics — Positive
DE Zacks Investment Research — May 12, 2025Beyond analysts' top -and-bottom-line estimates for Deere (DE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.
Curious about Walmart (WMT) Q1 Performance? Explore Wall Street Estimates for Key Metrics — Positive
WMT Zacks Investment Research — May 12, 2025Beyond analysts' top -and-bottom-line estimates for Walmart (WMT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.
Seeking Clues to Applied Materials (AMAT) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics — Positive
AMAT Zacks Investment Research — May 12, 2025Besides Wall Street's top -and-bottom-line estimates for Applied Materials (AMAT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended April 2025.
Did Arvinas, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ARVN — Neutral
ARVN Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Arvinas, Inc. ("Arvinas") (NASDAQ:ARVN) concerning possible violations of federal securities laws. On May 1, 2025, Arvinas issued a press release announcing a re-prioritization of its vepdegestrant development plan and research portfolio.
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
SANA Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sana-biotechnology-inc-lawsuit-submission-form?prid=148081&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Shareholders of Civitas Resources, Inc. (CIVI) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
CIVI Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=148082&wire=1 or contact Joseph E. Levi, Esq.
Shareholders That Lost Money on Open Lending Corporation (LPRO) Should Contact Levi & Korsinsky About Pending Class Action - LPRO — Neutral
LPRO Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=148085&wire=1 or contact Joseph E. Levi, Esq.
Geron Corporation Class Action: Levi & Korsinsky Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN — Neutral
GERN Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=148086&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Shareholders of Ibotta, Inc. (IBTA) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
IBTA Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=148083&wire=1 or contact Joseph E. Levi, Esq.
